Bristol-Myers Squibb Company
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 41.2B 45.0B 46.2B 46.4B
Cost of revenue 11.9B 10.7B 10.1B 9.9B
Gross profit 29.3B 34.3B 36.0B 36.4B
Operating expense
Research & development 9.5B 9.3B 9.5B 10.2B
Selling general and admin 7.2B 7.8B 7.8B 7.7B
Other operating expenses
Operating income 5.0B 8.2B 9.1B 8.5B
Non operating interest income
Income
Expense 1.7B 1.2B 1.2B 1.3B
Other income expense -10.5B 1.4B -159M 895M
Pretax income -7.1B 8.4B 7.7B 8.1B
Tax provision 472.1M 400M 1.4B 1.1B
Net income -7.6B 8.0B 6.3B 7.0B
Basic EPS -4.4 3.9 3.0 3.2
Diluted EPS -4.4 3.9 3.0 3.1
Basic average shares 1.7B 2.2B 2.2B 2.2B
Diluted average shares 1.7B 2.2B 2.2B 2.2B
EBITDA 14.6B 19.4B 20.6B 20.4B
Net income from continuing op. -7.6B 8.0B 6.3B 7.0B
Minority interests -15M -15M -18M -20M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 25 minutes

15:09
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).